Literature DB >> 22116709

Autoimmune diseases and polyamines.

Wesley H Brooks1.   

Abstract

Genetics and environmental factors have important roles in autoimmune diseases but neither has given us sufficient understanding of these mysterious diseases. Therefore, we are now looking closer at epigenetics, an interface between genetics and environmental factors. Epigenetics can be defined as reversible heritable changes to chromatin that can alter gene expression without altering the gene's DNA sequence. Methylation of DNA and histones are primary means of epigenetic control. By adding methyl groups to DNA and histones, it can limit accessibility of the underlying gene thereby altering the amount of gene expression. The methyl group is derived from an essential molecule in the cell, S-adenosylmethionine (SAM). However, a group of small molecules called polyamines also require SAM for their synthesis. Polyamines are essential for many cellular functions and polyamine activity is increased in many autoimmune diseases. Presented here is the "polyamine hypothesis" in which increased polyamine synthesis competes with cellular methylation (epigenetic control) for SAM. It is proposed that increased polyamine activity can cause disruption of cellular methylation, which can lead to abnormal expression of previously sequestered genes and disruption of other methylation-dependent cellular processes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22116709     DOI: 10.1007/s12016-011-8290-y

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  111 in total

1.  LINE-1 elements and X chromosome inactivation: a function for "junk" DNA?

Authors:  M F Lyon
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

2.  Polyamines are potent ligands for the capsaicin receptor TRPV1.

Authors:  Gerard P Ahern; Xiangbin Wang; Rosa Linda Miyares
Journal:  J Biol Chem       Date:  2006-01-23       Impact factor: 5.157

Review 3.  Primary kidney growth and its consequences at the onset of diabetes mellitus.

Authors:  J Satriano; V Vallon
Journal:  Amino Acids       Date:  2006-05-29       Impact factor: 3.520

4.  X-inactivation profile reveals extensive variability in X-linked gene expression in females.

Authors:  Laura Carrel; Huntington F Willard
Journal:  Nature       Date:  2005-03-17       Impact factor: 49.962

5.  Lupus like lesions in a patient with X-linked chronic granulomatous disease and recombinant X chromosome.

Authors:  P L Ortiz-Romero; A Corell-Almuzara; J L Lopez-Estebaranz; F R Arranz; J Ruiz-Contreras
Journal:  Dermatology       Date:  1997       Impact factor: 5.366

6.  LINE-mediated retrotransposition of marked Alu sequences.

Authors:  Marie Dewannieux; Cécile Esnault; Thierry Heidmann
Journal:  Nat Genet       Date:  2003-08-03       Impact factor: 38.330

7.  Demethylation of CD40LG on the inactive X in T cells from women with lupus.

Authors:  Qianjin Lu; Ailing Wu; Laura Tesmer; Donna Ray; Neda Yousif; Bruce Richardson
Journal:  J Immunol       Date:  2007-11-01       Impact factor: 5.422

8.  Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity.

Authors:  E Cornacchia; J Golbus; J Maybaum; J Strahler; S Hanash; B Richardson
Journal:  J Immunol       Date:  1988-04-01       Impact factor: 5.422

9.  Immunocytochemical demonstration of polyamines in nucleoli and nuclei.

Authors:  Masashi Shin; Hiromichi Nakamuta; Naoko Oda-Ueda; Lars-Inge Larsson; Kunio Fujiwara
Journal:  Histochem Cell Biol       Date:  2008-02-27       Impact factor: 4.304

Review 10.  Polyamines, chromatin structure and transcription.

Authors:  H R Matthews
Journal:  Bioessays       Date:  1993-08       Impact factor: 4.345

View more
  15 in total

Review 1.  Molecular mechanisms in autoimmune type 1 diabetes: a critical review.

Authors:  Zhiguo Xie; Christopher Chang; Zhiguang Zhou
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

Review 2.  Review of the "X chromosome-nucleolus nexus" hypothesis of autoimmune diseases with an update explaining disruption of the nucleolus.

Authors:  Wesley H Brooks
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

Review 3.  Epigenetics in the pathogenesis of RA.

Authors:  Caroline Ospelt; Steffen Gay; Kerstin Klein
Journal:  Semin Immunopathol       Date:  2017-03-21       Impact factor: 9.623

Review 4.  A Review of Autoimmune Disease Hypotheses with Introduction of the "Nucleolus" Hypothesis.

Authors:  Wesley H Brooks
Journal:  Clin Rev Allergy Immunol       Date:  2017-06       Impact factor: 8.667

Review 5.  Matching the power of high throughput screening to the chemical diversity of natural products.

Authors:  Curtis J Henrich; John A Beutler
Journal:  Nat Prod Rep       Date:  2013-08-08       Impact factor: 13.423

6.  Sex-related differences in urinary immune-related metabolic profiling of alopecia areata patients.

Authors:  Yu Ra Lee; Haksoon Kim; Bark Lynn Lew; Woo Young Sim; Jeongae Lee; Han Bin Oh; Jongki Hong; Bong Chul Chung
Journal:  Metabolomics       Date:  2020-01-16       Impact factor: 4.290

7.  Protective effects of polyamine depletion in mouse models of type 1 diabetes: implications for therapy.

Authors:  Sarah A Tersey; Stephanie C Colvin; Bernhard Maier; Raghavendra G Mirmira
Journal:  Amino Acids       Date:  2013-07-12       Impact factor: 3.520

8.  Genetic variant of AMD1 is associated with obesity in urban Indian children.

Authors:  Rubina Tabassum; Alok Jaiswal; Ganesh Chauhan; Om Prakash Dwivedi; Saurabh Ghosh; Raman K Marwaha; Nikhil Tandon; Dwaipayan Bharadwaj
Journal:  PLoS One       Date:  2012-04-09       Impact factor: 3.240

9.  Increased polyamines alter chromatin and stabilize autoantigens in autoimmune diseases.

Authors:  Wesley H Brooks
Journal:  Front Immunol       Date:  2013-04-17       Impact factor: 7.561

10.  Epigenetics and autoimmune diseases: the X chromosome-nucleolus nexus.

Authors:  Wesley H Brooks; Yves Renaudineau
Journal:  Front Genet       Date:  2015-02-16       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.